Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Keratosis × BF-200 ALA × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Dermatologic 1

Conditions

Keratosis, Actinic 4 Skin Diseases 1 Precancerous Conditions 1 Neoplasms, Basal Cell 1 Keratosis 1 Hutchinson's Melanotic Freckle 1 Carcinoma, Basal Cell 1

Interventions

tirbanibulin 2 Imiquimod 2 Cryotherapy 2 Tomography, Optical Coherence 1 BF-200 ALA 1 3-ingenyl angelate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05060237 2024-10-17

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Biofrontera Bioscience GmbH

Phase 1 Completed

112 enrolled 21 charts

DermatologicOther neoplasm

Keratosis, Precancerous Conditions, Skin Diseases, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡